# Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa

> **NCT01819155** · PHASE2 · COMPLETED · sponsor: **PATH** · enrollment: 296 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Adjuvanted seasonal trivalent inactivated influenza vaccine
- **BIOLOGICAL:** Seasonal trivalent inactivated influenza vaccine
- **BIOLOGICAL:** Saline (bacteriostatic 0.9% sodium chloride for injection)

## Key facts

- **NCT ID:** NCT01819155
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2013-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819155, "Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01819155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*